DUXAP9 and urinary bladder cancer: These results suggest that LNMAT1-induced CCL2 modulates the bladder cancer microenvironment by regulating TAMs infiltration and VEGF-C upregulation, ultimately resulting in lymphangiogenesis and lymphatic metastasis.